Latham & Watkins and Baker McKenzie advised ZF Friedrichshafen AG (ZF) on the deal. Noerr advised AEQUITA. ZF Friedrichshafen AG (ZF) announced the carve-out and sale...
Aequita’s Acquisition of ZF’s Global Electronic Interfaces Product Line
Clearlake and Motive’s $1,100 Million Acquisition of BETA+
Latham & Watkins represented London Stock Exchange Group in the transaction while Sidley advised Clearlake Capital Group, L.P. and Motive Partners. London Stock Exchange Group plc...
Ara Partners’ Investment in CycleØ
Latham & Watkins represented Ara Partners in the transaction. Ara Partners, a private equity firm that specialises in industrial decarbonisation investments, has announced its partnership to...
OXIO’s $40 Million Series B Funding
Latham & Watkins represented ParaFi Capital in the transaction. OXIO, the first telecom-as-a-service platform for brands and enterprises with a white-label, fully-customizable solution to help turn...
Vira Health’s $12 Million Funding Round
Latham & Watkins has advised Octopus Ventures as lead investor on the round. Vira Health, a digital health company focused on improving the long-term health of...
Thoma Bravo’s Acquisition of Anaplan
Gunderson Dettmer and Skadden advised Anaplan on the deal. Kirkland and Ellis and Cadwalader, Wickersham & Taft advised Thoma Bravo. Latham & Watkins represented the direct...
Textron’s Acquisition of Pipistrel
Latham & Watkins and Ketler & Partners represented Textron in the transaction, Fabiani, Petrovic, Jeraj, Rejc Attorneys-at-Law advised Pipistrel Group. Textron Inc. (NYSE: TXT), home to...
Vapotherm’s $100 Million Debt Facility
Latham & Watkins represented SLR Investment Corp. in the transaction. Vapotherm, Inc., a global medical technology company focused on the development and commercialization of non-invasive technologies...
Triumvira Immunologics’ $100 Million Series A Financing Round
Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...
Clarify Health’s Acquisition of Embedded Healthcare
Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced the acquisition of Embedded...
Revel Games’ $4.5 Million Seed Investment Round
Latham & Watkins advised Garena, while BTS & Partners advised Revel Games on the deal. Istanbul-based mobile gaming company Revel Games, focused on developing new games...
ConsenSys’ $450 Million Series D Funding
Latham & Watkins represented ParaFi Capital in the transaction. ConsenSys closed a US$450 million financing round, bringing its valuation to over US$7 billion. ParaFi Capital led this...